NOVOCURE LTD - NOTE 11/0

CUSIP: 67011XAB9

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Debt / NOTE 11/0
Market price (% of par)
86.1%
Total 13F principal
$559,014,992
Principal change
+$30,932,793
Total reported market value
$485,774,358
Number of holders
24
Value change
+$25,007,148
Number of buys
9
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 67011XAB9?
CUSIP 67011XAB9 identifies 67011XAB9 - NOVOCURE LTD - NOTE 11/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVOCURE LTD - NOTE 11/0 as of Q3 2023

As of 30 Sep 2023, NOVOCURE LTD - NOTE 11/0 was held by 24 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $559,014,992 in principal (par value) of the bond. The largest 10 bondholders included BRAIDWELL LP, TENOR CAPITAL MANAGEMENT Co., L.P., Opti Capital Management, LP, Voya Investment Management LLC, DeepCurrents Investment Group LLC, Linden Advisors LP, STEELHEAD PARTNERS LLC, Balyasny Asset Management L.P., STATE STREET CORP, and CAPSTONE INVESTMENT ADVISORS, LLC. This page lists 24 institutional bondholders reporting positions for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.